Abstract
In September, an outbreak of fungal meningitis due to contaminated steroid injections prepared by the New England Compounding Center (NECC) began in Tennessee. When this issue of Pharmacy Today went to press, 268 cases of this rare and potentially fatal—albeit noncontagious— disease had been reported in 16 states; 21 patients had reportedly died. This contamination has been described as "unprecedented" in a New England Journal of Medicine review.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
